# Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

> **NCT07562763** · — · COMPLETED · sponsor: **Anhui Provincial Hospital** · enrollment: 1005 (actual)

## Conditions studied

- Hepatocellular Carcinoma (HCC)
- Transarterial Chemoembolization
- Adjuvant Therapy
- Machine Learning
- Treatment Effectiveness

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07562763
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 1005 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07562763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07562763, "Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07562763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*